Resuscitation Devices Market

Executive Summary

Resuscitation Devices Market was valued at US $86.42 million in 2021 and is projected to grow at 12.91% CAGR over the forecast period to reach US $179.07 million by 2027. Resuscitation Devices Market represented US $18.63 million opportunity over 2019-2021 and estimated to create US $92.65 million opportunity in 2027 over 2021.

Resuscitation Devices from Consainsights analyses the Resuscitation Devices Market in the Life Sciences industry over the forecast period to 2027.

Resuscitation Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Resuscitation Devices segmentation includes Product, Patient Type, End User, Region and Geography.

Based on the Product, the Resuscitation Devices analysis covers Airway Management Devices, External Defibrillators, Convective Warming Blankets, Other Resuscitation Devices.

In Product segment, Airway Management Devices segment has highest cagr growth of 11.40%.

Based on the Patient Type, the Resuscitation Devices analysis covers Adult Patients, Pediatric Patients.

In Patient Type segment, Adult Patients segment has highest cagr growth of 11.40%.

Based on the End User, the Resuscitation Devices analysis covers Hospitals, Ambulatory Surgical Centers, and Cardiac Centers, Pre-Hospital Care Settings, Other End Users.

In End User segment, Other End Users segment has highest cagr growth of 11.40%.

Based on the Region, the Resuscitation Devices analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 11.40%.

Based on the region, the Resuscitation Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Koninklijke Philips N.V., Medtronic Plc, Zoll Medical (A Part of Asahi Kasei), Physio-Control (A Part of Stryker Corporation), Drägerwerk Ag & Co. KGaA, Cardinal Health, Smiths Medical (A Division of Smiths Group Plc), Mindray Medical, Nihon Kohden, Teleflex, Resmed, Inc., Ambu, Salter Labs, GE Healthcare, Verathon (A Part of Roper Technologies), Vyaire Medical, Intersurgical, Company, Flexicare, KARL STORZ and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Airway Management Devices segment has the highest revenue of US $32.45 million and is expected to grow at CAGR of 11.40% by 2027 Airway Management Devices segment has highest cagr growth of 11.40%.

Airway Management Devices

Airway Management Devices segment was valued at US $25.45 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $67.23 million by 2027. Airway Management Devices segment represented US $7.00 million opportunity over 2019-2021 and estimated to create US $34.78 million opportunity in 2027 over 2021.

External Defibrillators

External Defibrillators segment was valued at US $22.78 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $60.19 million by 2027. External Defibrillators segment represented US $6.26 million opportunity over 2019-2021 and estimated to create US $31.14 million opportunity in 2027 over 2021.

Convective Warming Blankets

Convective Warming Blankets segment was valued at US $9.49 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $25.08 million by 2027. Convective Warming Blankets segment represented US $2.61 million opportunity over 2019-2021 and estimated to create US $12.98 million opportunity in 2027 over 2021.

Other Resuscitation Devices

Other Resuscitation Devices segment was valued at US $10.06 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $26.57 million by 2027. Other Resuscitation Devices segment represented US $2.77 million opportunity over 2019-2021 and estimated to create US $13.75 million opportunity in 2027 over 2021.

Patient Type

Introduction

In 2021, Adult Patients segment has the highest revenue of US $49.78 million and is expected to grow at CAGR of 11.40% by 2027 Adult Patients segment has highest cagr growth of 11.40%.

Adult Patients

Adult Patients segment was valued at US $39.05 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $103.15 million by 2027. Adult Patients segment represented US $10.73 million opportunity over 2019-2021 and estimated to create US $53.37 million opportunity in 2027 over 2021.

Pediatric Patients

Pediatric Patients segment was valued at US $28.74 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $75.92 million by 2027. Pediatric Patients segment represented US $7.90 million opportunity over 2019-2021 and estimated to create US $39.28 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals, Ambulatory Surgical Centers, and Cardiac Centers segment has the highest revenue of US $38.90 million and is expected to grow at CAGR of 11.40% by 2027 Other End Users segment has highest cagr growth of 11.40%.

Hospitals, Ambulatory Surgical Centers, and Cardiac Centers

Hospitals, Ambulatory Surgical Centers, and Cardiac Centers segment was valued at US $30.51 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $80.60 million by 2027. Hospitals, Ambulatory Surgical Centers, and Cardiac Centers segment represented US $8.39 million opportunity over 2019-2021 and estimated to create US $41.70 million opportunity in 2027 over 2021.

Pre-Hospital Care Settings

Pre-Hospital Care Settings segment was valued at US $20.60 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $54.41 million by 2027. Pre-Hospital Care Settings segment represented US $5.66 million opportunity over 2019-2021 and estimated to create US $28.15 million opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $16.68 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $44.05 million by 2027. Other End Users segment represented US $4.58 million opportunity over 2019-2021 and estimated to create US $22.79 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $36.07 million and is expected to grow at CAGR of 11.40% by 2027 North America segment has highest cagr growth of 11.40%.

North America

North America segment was valued at US $28.29 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $74.73 million by 2027. North America segment represented US $7.78 million opportunity over 2019-2021 and estimated to create US $38.66 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $17.72 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $46.82 million by 2027. Europe segment represented US $4.87 million opportunity over 2019-2021 and estimated to create US $24.22 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $12.94 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $34.19 million by 2027. Asia Pacific segment represented US $3.56 million opportunity over 2019-2021 and estimated to create US $17.69 million opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $8.83 million in 2019 and is projected to grow at 11.40% CAGR over the forecast period to reach US $23.33 million by 2027. Rest of the World segment represented US $2.43 million opportunity over 2019-2021 and estimated to create US $12.07 million opportunity in 2027 over 2021.